Methotrexate

You have access
Methotrexate in rheumatoid arthritis: when NSAIDs fail
John A. Flynn, MD and David B. Hellmann, MD

Cleveland Clinic Journal of Medicine November 1995, 62 (6) 351-359;

With diligent monitoring, low-dose methotrexate is effective for treating selected patients with rheumatoid arthritis, and it is safer than previously thought.
You have access
Response of immunoregulatory lymphocyte subsets to methotrexate in rheumatoid arthritis
Leonard H. Calabrese, DO, John V. Taylor, MD, William S. Wilke, MD, Allen M. Segal, DO, Rafael Valenzuela, MD, PhD and John D. Clough, MD

Cleveland Clinic Journal of Medicine May 1990, 57 (3) 232-241;
You have access
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis
Patricia L. Krall, PA-C, Daniel J. Mazanec, MD and William S. Wilke, MD

Cleveland Clinic Journal of Medicine May 1989, 56 (3) 253-257;
You have access
Drug-induced osteoporosis
Daniel J. Mazanec, MD and Joseph M. Grisanti, MD

Cleveland Clinic Journal of Medicine May 1989, 56 (3) 297-303;
You have access
Methotrexate in the treatment of arthritis and connective tissue diseases
William S. Wilke, M.D., Jeffrey A. Biro, D.O. and Allen M. Segal, D.O.

Cleveland Clinic Journal of Medicine July 1987, 54 (4) 327-338;
You have access
Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis
Allen H. Mackenzie, M.D.

Cleveland Clinic Journal of Medicine June 1985, 52 (2) 129-135;
You have access
Childhood-onset pityriasis rubra pilaris treated with methotrexate administered intravenously
C. William Hanke, M.D. and Willard D. Steck, M.D.

Cleveland Clinic Journal of Medicine June 1983, 50 (2) 201-203;

Main menu

User menu

Search

Methotrexate

Navigate

Authors & Reviewers